Heron Therapeutics, Inc.

符号: HRTX

NASDAQ

2.45

USD

今天的市场价格

-3.3392
市盈率
0.0254
PEG比率
368.31M
MRK市值
0.00%
DIV收益率

Heron Therapeutics, Inc. (HRTX) 财务报表

Q: 什么是 Heron Therapeutics, Inc. (HRTX) 总资产是多少？

Heron Therapeutics, Inc. (HRTX) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Heron Therapeutics, Inc. (HRTX). 的默认数据。公司收入显示 22.897 M 的平均值，即 0.785 % 增长率。整个期间的平均毛利润为 13.082 M，即 0.677 %. 平均毛利率为 0.632 %. 公司去年的净收入增长率为 -0.178 %，等于 -0.089 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Heron Therapeutics, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.113. 在流动资产领域，HRTX 的报告货币为188.774. 这些资产中的很大一部分，即 80.409 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.052%. 公司的长期投资虽然不是其重点，但以报告货币计算的0（如果有的话）为0。这表明与上一报告期相比，0.000% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 173.753. 这一数字表明，0.141% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 -33.973. 这方面的年同比变化率为 -3.503%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为60.137，存货估值为 42.11，商誉估值为 0（如有. 无形资产总额（如果有）按 0 估值. 应付账款和短期债务分别为 3.24 和 3.08. 债务总额为179.63，债务净额为 150.95. 其他流动负债为 73.37，加上总负债 256.48. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990	1988
balance-sheet.row.cash-and-short-term-investments	251.09	80.4	84.9	157.6	208.5	391	332.4	172.4	51.1	131.2	72.7	72.3	53.5	18	2.1	7.6	10.5	35.1	15.5	5.8	13.6	9.5	14.1	19.5	22.5	3.7	4.1	8.7	5.4	5.2	2.7	1.8	2.7	1.6	1.7	2.6	11.4	15.9
balance-sheet.row.short-term-investments	147	51.7	69.5	67	103.4	319.1	300.5	27.8	37.7	56	0	0	0	0	0	0	0.6	1.6	13.2	5	10.5	9.4	10.8	15.9	16	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	252.07	60.1	52	35.5	41.9	39.9	64.7	41.9	2	0	0	0	0	0	0.1	0.2	0	0.2	0.1	1.5	1.5	1.3	1.5	1.5	1.7	5.1	4.8	3.4	1.7	2.5	1.9	2.8	1.6	1.2	1	0.7	0.7	0.6
balance-sheet.row.inventory	180.8	42.1	54.6	48.4	41.9	25	39	10.1	5.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	4.6	3	2.6	2.1	7.9	7	8.4	1.4	0.5	0.3	0.1	0.1	0
balance-sheet.row.other-current-assets	42.23	6.1	14	13	21.9	23.2	11.2	3.7	3.7	3.6	1.1	0.6	0.6	0.3	0.3	0.5	0.2	0.6	0.6	0.3	0.4	0.4	0.3	0.6	0.8	0.4	0.9	0.5	2.5	0.9	4.8	2.1	13.4	1.4	3.2	5.4	0.1	0
balance-sheet.row.total-current-assets	726.19	188.8	205.4	254.4	314.2	479.1	447.2	228.1	62.1	134.8	73.7	72.9	54.1	18.2	2.5	8.3	10.8	35.8	16.2	7.6	15.5	11.3	16	21.6	25	13.8	12.8	15.2	11.7	16.5	16.4	15.1	19.1	4.7	6.2	8.8	12.3	16.5
balance-sheet.row.property-plant-equipment-net	108.4	25.6	29.8	33.6	39	33.4	14.7	6	5.1	3	2.8	2.9	1.8	1.1	0.4	0.5	0.9	1.1	1	1.2	1.2	1.4	1.6	1.7	1.8	8	8.6	6.8	4.7	5	5.1	5.4	4.9	3.2	3.8	4.3	4.3	4.2
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	1.4	1.5	0.1	0.2	0.3	0.5	0.7	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	1.4	1.5	0.1	0.2	0.3	0.5	0.7	0	0	0	0	0
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	39.21	8.1	15.7	17.7	0.3	0.3	0.3	0.3	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.5	0.2	0.2	0.2	0.4	0.3	0.7	1.9	1.4	1.7	3.4	3.6	1.7	1.6	0.1	0.2	0.3
balance-sheet.row.total-non-current-assets	147.62	33.7	45.5	51.3	39.4	33.7	14.9	6.2	5.3	3.1	3	3	1.9	1.2	0.4	0.6	1	1.2	1	1.3	1.5	1.9	1.8	1.9	1.9	9.7	10.3	9	6.7	6.6	7.1	9.3	9.2	4.9	5.4	4.4	4.5	4.5
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	873.81	222.5	251	305.7	353.6	512.8	462.2	234.3	67.5	137.8	76.7	75.9	56	19.4	2.9	9	11.8	37	17.3	9	17	13.2	17.8	23.5	27	23.5	23.1	24.2	18.4	23.1	23.5	24.4	28.3	9.6	11.6	13.2	16.8	21
balance-sheet.row.account-payables	11.12	3.2	3.2	3.8	0.5	2.8	17.1	18.9	7.9	3.3	3.4	1.3	1.9	1	0.2	0.2	0.3	1.4	0.8	0.6	0.7	0.5	0.3	0.3	0.3	1	1.3	1.6	2.3	7.5	6.2	7.3	0.6	0.4	0.4	0.3	0	0
balance-sheet.row.short-term-debt	11.42	3.1	2.7	2.4	10.1	7.5	4.6	28.7	2.9	2.2	1.6	1	0.5	0.1	0	0	-1	-1	-1	0	0	0	0	1.4	0	0.9	3.1	2.5	0.8	0.9	2.2	0.3	0.3	0	0	0	0	0.1
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	658.46	173.8	154.8	157.1	14.6	12.2	0	0	50	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	3.1	5.6	6.4	1	3.4	3.7	4	3	3	3	3.1
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	301.51	73.4	76.4	64.8	91.9	86.4	70.4	52.8	26.9	14.2	8.6	4.7	1.8	0.4	1.2	1.6	2.8	4.8	3.4	2.2	2.2	1.2	1.5	1.5	4.6	2.5	3.1	6.8	4.8	3.1	2.3	2.9	3.5	2	1.9	0.4	0.6	0.6
balance-sheet.row.total-non-current-liabilities	662.23	176.8	155	157.1	14.6	12.2	0	0	50	0	0	0	0	0	0	0.3	1	1.3	1	0	0	0	0.3	0.8	0.9	7.1	1.1	3.1	5.5	6.4	1	3.4	3.7	4	3	3	2.9	3.1
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	23.67	2.8	8.2	10.4	17.6	14.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	986.28	256.5	237.4	228.1	117.1	108.9	92	103.2	88.7	19.7	13.6	7	4.2	3.7	1.6	2.2	4.2	7.5	5.2	2.8	2.9	1.9	2.3	4.3	5.8	11.5	8.6	14	13.4	17.9	11.7	13.9	8.1	6.4	5.3	3.7	3.5	3.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	5.31	1.5	1.2	1	0.9	0.9	0.8	0.6	0.4	0.4	0.3	0.2	3	2	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-7499.81	-1906	-1795.5	-1613.4	-1392.7	-1165.5	-960.7	-783.5	-586	-412.8	-315.2	-238.9	-183.6	-160.2	-148.4	-141.1	-131.1	-107.9	-87.8	-93	-84.8	-75.6	-71.2	-67.5	-64.9	-73.5	-70.4	-72.3	-71.6	-62.2	-52.8	-43	-33	-27.4	-23.1	-19.2	-14.7	-9.7
balance-sheet.row.accumulated-other-comprehensive-income-loss	0.01	0	0	0	0.3	0.1	-0.1	0	0	0	-4.8	-4.3	-4.4	-4.3	-4.2	0	0	0	0	0	0	0	0.1	0.2	0	-0.2	-9.3	-9.5	-8.8	-7.9	-7	-6	-5.1	-4.4	-3.7	-2.9	-2.3	-1.2
balance-sheet.row.other-total-stockholders-equity	7382.02	1870.5	1807.9	1690	1628.1	1568.3	1330.2	914	564.3	530.6	382.8	311.9	236.8	178.3	153.5	147.5	138.4	137.1	99.6	99	98.7	86.6	86.4	89.4	88.7	95.4	94.2	92	85.4	75.3	71.6	59.5	58.3	34.9	33.1	31.6	30.3	28.1
balance-sheet.row.total-stockholders-equity	-112.47	-34	13.6	77.6	236.5	403.8	370.2	131.1	-21.3	118.1	63.1	68.9	51.8	15.8	1.3	6.8	7.6	29.5	12.1	6.2	14.2	11.3	15.5	19.2	21.2	12	14.5	10.2	5	5.2	11.8	10.5	20.2	3.1	6.3	9.5	13.3	17.2
balance-sheet.row.total-liabilities-and-stockholders-equity	873.81	222.5	251	305.7	353.6	512.8	462.2	234.3	67.5	137.8	76.7	75.9	56	19.4	2.9	9	11.8	37	17.3	9	17	13.2	17.8	23.5	27	23.5	23.1	24.2	18.4	23.1	23.5	24.4	28.3	9.6	11.6	13.2	16.8	21
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0
balance-sheet.row.total-equity	-112.47	-34	13.6	77.6	236.5	403.8	370.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	873.81	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	147	51.7	69.5	67	103.4	319.1	300.5	27.8	37.7	56	0	0	0	0	0	0	0.6	1.6	13.2	5	10.5	9.4	10.8	15.9	16	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	672.68	179.6	157.5	159.5	24.6	19.8	4.6	28.7	52.9	2.2	1.6	1	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	3.3	3.1	5.6	6.4	7.3	3.2	3.7	4	4	3	3	3	3.2
balance-sheet.row.net-debt	568.59	151	142.1	69	-80.5	-52.1	-27.3	-115.9	39.5	-73	-71.1	-71.3	-53	-17.9	-2.1	-7.6	-10	-33.5	-2.3	-0.8	-3.1	-0.1	-3.3	-3.6	-6.5	-0.4	-1	-3.1	1	2.1	0.5	1.9	1.3	2.4	1.3	0.4	-8.4	-12.7

现金流量表

在 Heron Therapeutics, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.594 的转变。该公司最近通过发行 29.76 扩大了股本，与上一年相比出现了26.196 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 0.01. 公司的投资活动产生了现金使用净额，按报告货币计算达到17995000.000. 与上一年相比， -6.414 发生了变化. 在同一时期，公司记录了 2.9, 0 和 -24.35，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 48.7，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990
cash-flows.row.net-income	-110.56	-110.6	-182	-220.7	-227.3	-204.7	-178.8	-197.5	-173.1	-97.6	-76.4	-55.3	-24.4	0.4	-7.2	-10.1	-22.9	-20.2	5.3	-8.2	-9.2	-4.4	-3.8	-2.5	8.6	2.4	1.9	-0.7	-9.4	-9.4	-9.8	-9.9	-5.6	-4.3	-3.9	-4.5
cash-flows.row.depreciation-and-amortization	2.9	2.9	2.9	3	2.8	2	1.5	1.5	1.1	0.7	0.6	0.3	0.2	0.2	0.2	0.4	0.4	0.3	-0.2	0.4	0.3	0.5	0.5	0.4	-0.1	0.5	1.4	1.2	1.4	1.2	1.1	1.2	1.1	0.8	0.8	0.7
cash-flows.row.deferred-income-tax	-1.19	-4.4	0	1.6	1	-3.6	-3.3	-0.2	0.3	0	0.9	0	0	0.1	-0.1	0	-0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	32.85	32.9	43	46.9	50.2	51.4	33.4	30.5	26	14.4	8.1	10.9	5.7	1.9	1.7	1.1	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	16.79	16.8	-10.5	-35.1	-13	29.2	-45.4	-5.4	11	3.4	5.9	2.8	1.1	1.5	-0.3	-2.4	-3	2.1	3.5	-0.1	0.8	-0.4	-0.8	-1.2	-0.6	-2.7	-5	-0.9	0.3	-0.9	-0.6	-3.7	0.4	-0.4	-0.2	-0.5
cash-flows.row.account-receivables	-8.09	-8.1	-16.6	6.4	-2	24.8	-22.8	-39.9	-2	0	0	0	0	0.1	0.1	-0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	12.46	12.5	-6.2	-6.5	-16.9	14.1	-29.1	-4.8	-5.3	0	0	0	0	1.3	-0.3	-2.1	-2	0	0	0	0	0	0	0	0	-1.6	-0.3	-0.6	5.6	-0.9	1.3	-5.1	-1.2	-0.2	-0.1	-0.1
cash-flows.row.account-payables	0.01	0	-0.6	3.3	-2.2	-14.1	-1.9	12	3.5	0.8	1.3	-0.4	1	0.5	0	-0.2	-1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	12.93	12.4	12.8	-38.2	8.1	4.5	8.4	27.3	14.8	2.6	4.7	3.2	0.1	-0.3	0	0	0	2.1	3.5	-0.1	0.8	-0.4	-0.8	-1.2	-0.6	-1.1	-4.7	-0.3	-5.3	0	-1.9	1.4	1.6	-0.2	-0.1	-0.4
cash-flows.row.other-non-cash-items	0.41	3.6	-0.3	0.9	1.4	1.1	0.9	0.8	0.7	0.6	0.6	0.5	0.4	-11.8	0.2	0	0.3	0.5	0.7	0.3	0.3	-2.2	-1	-3.2	-10.9	-0.8	0.2	0.4	1.6	0.6	0.7	0.7	0.2	0.1	-0.1	0.5
cash-flows.row.net-cash-provided-by-operating-activities	-58.79	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-1.54	-1.5	-1.8	-3	-6.8	-7.2	-9.2	-2.6	-3.1	-1.1	-1.4	-1.7	-1	-0.5	-0.1	0	-0.3	-0.5	-0.2	-0.3	-0.2	-0.3	-0.4	-0.3	-0.2	-0.3	-2.7	-2.8	-0.7	-0.9	-0.6	-1.2	-2.4	-0.1	-0.2	-0.7
cash-flows.row.acquisitions-net	-28.11	0	0.2	0	-215.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0.5	0	0	0	0
cash-flows.row.purchases-of-investments	-87.66	-87.7	-145.7	-129.2	-134	-477	-497.1	-121.6	-43.3	-56.1	0	0	0	0	0	0	0	0	-14.7	-8.1	-17.3	-6.7	-12.6	-16.4	-18.9	0	-0.1	0	-0.5	-4.5	-1.4	-6.5	-15.5	-2.3	-7	-1
cash-flows.row.sales-maturities-of-investments	107.19	107.2	144	164.9	349.8	462.4	227.7	131.8	61.3	0	0	0	0	0	0	0.6	1	11.7	7.2	13.5	16.3	8.1	17.5	16.6	3	0	0	0	0.5	5.9	1.2	18.1	3.6	4	7.7	0
cash-flows.row.other-investing-activites	19.54	0	0	0	215.8	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	2.1	0.2	3.6	25	-0.1	0	1.8	0	0.1	-0.1	-0.2	-0.1	0	-0.1	0
cash-flows.row.net-cash-used-for-investing-activites	18	18	-3.3	32.7	209	-21.8	-278.6	7.7	14.9	-57	-1.4	-1.7	-1	-0.5	-0.1	0.6	0.7	11.2	-7.7	5.1	-1.3	3.3	4.7	3.5	9	-0.4	-2.8	-1	-0.7	1.4	-0.9	10.7	-14.4	1.6	0.4	-1.7
cash-flows.row.debt-repayment	-83.86	-24.4	0	-149	0	0	-25	-25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	29.76	29.8	75.1	7.1	9.1	162.2	363.1	306.3	0	128.2	58.9	57.8	50.5	22.8	0	8	0.1	37.3	0.1	0.1	12	0.1	0.1	0.1	0.2	0.4	2.3	5.8	7.2	2.5	6	0.3	9.6	1.1	0.7	0.7
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	108.52	48.7	-0.1	297.9	0.1	24.3	19.5	12.5	57.5	9.8	3.2	3.4	3	1.3	0	0	0	0	0	0	0	0	0	0	-3.3	0.2	-2.6	-1.5	-0.1	7.1	4.5	-0.4	9.9	1	1.5	0
cash-flows.row.net-cash-used-provided-by-financing-activities	54.11	54.1	75.1	156	9.1	186.4	357.6	293.7	57.5	138	62.1	61.2	53.5	24.1	0.1	8	0.1	37.3	0.1	0.1	12	0.1	0.1	0.1	-3.1	0.6	-0.3	4.3	7.1	9.6	10.5	-0.1	19.5	2.1	2.2	0.7
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	13.31	13.3	-75.2	-14.6	33.2	40.1	-112.7	131.2	-61.8	2.5	0.4	18.8	35.5	15.9	-5.5	-2.4	-23.5	31.2	1.5	-2.3	3	-3.2	-0.3	-2.9	2.8	-0.4	-4.6	3.1	0.3	2.5	1	-1.1	1.2	-0.1	-0.8	-4.8
cash-flows.row.cash-at-end-of-period	104.09	28.7	15.4	90.5	105.1	71.9	31.8	144.6	13.4	75.2	72.7	72.3	53.5	18	2.1	7.6	10	33.5	2.3	0.8	3.1	0.1	3.3	3.6	6.5	3.7	4.1	8.5	5.4	5.2	2.8	1.7	2.8	1.6	1.8	2.6
cash-flows.row.cash-at-beginning-of-period	90.78	15.4	90.5	105.1	71.9	31.8	144.6	13.4	75.2	72.7	72.3	53.5	18	2.1	7.6	10	33.5	2.3	0.8	3.1	0.1	3.3	3.6	6.5	3.7	4.1	8.7	5.4	5.1	2.7	1.8	2.8	1.6	1.7	2.6	7.4
cash-flows.row.operating-cash-flow	-58.79	-58.8	-146.9	-203.4	-184.8	-124.6	-191.8	-170.3	-134.1	-78.5	-60.3	-40.8	-17	-7.7	-5.5	-11	-24.3	-17.3	9.2	-7.5	-7.7	-6.5	-5.1	-6.5	-3.1	-0.6	-1.5	-0.2	-6.1	-8.5	-8.6	-11.7	-3.9	-3.8	-3.4	-3.8
cash-flows.row.capital-expenditure	-1.54	-1.5	-1.8	-3	-6.8	-7.2	-9.2	-2.6	-3.1	-1.1	-1.4	-1.7	-1	-0.5	-0.1	0	-0.3	-0.5	-0.2	-0.3	-0.2	-0.3	-0.4	-0.3	-0.2	-0.3	-2.7	-2.8	-0.7	-0.9	-0.6	-1.2	-2.4	-0.1	-0.2	-0.7
cash-flows.row.free-cash-flow	-60.33	-60.3	-148.7	-206.4	-191.6	-131.7	-201	-172.9	-137.2	-79.6	-61.7	-42.4	-18	-8.2	-5.6	-11	-24.6	-17.8	9	-7.8	-7.9	-6.8	-5.6	-6.8	-3.3	-0.9	-4.2	-3	-6.8	-9.4	-9.2	-12.9	-6.3	-3.9	-3.6	-4.5

利润表行

Heron Therapeutics, Inc. 的收入与上期相比变化了 0.180%。据报告, HRTX 的毛利润为 61.94。该公司的营业费用为 172.55，与上年相比变化了 -24.137%. 折旧和摊销费用为 2.9，与上一会计期间相比变化了 0.003%. 营业费用报告为 172.55，显示-24.137% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.367%. 营业收入为 -110.61，与上年相比变化了-0.367%. 净利润的变化率为 -0.178%。去年的净收入为-110.56.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990	1988
income-statement-row.row.total-revenue	127.04	127	107.7	86.3	88.6	146	77.5	30.8	1.3	0	0	0	0	0.6	1.3	1.3	0.4	0.4	0	5.4	5.4	4.8	5.8	4.4	3.4	20.4	20	18.3	18.7	16.1	15.9	19.9	7.3	2.8	2.4	2.8	2.5	1.7
income-statement-row.row.cost-of-revenue	65.11	65.1	54.9	46	36.2	61.6	27.5	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0.6	6.4	5.7	6	9.4	9.8	9	11.6	3.8	1.1	1.2	0.7	0.6	0.4
income-statement-row.row.gross-profit	61.94	61.9	52.8	40.3	52.4	84.3	50	26.2	1.2	0	0	0	0	0.6	1.3	1.3	0.4	0.4	0	5.4	5.4	4.8	5.4	3.9	2.8	14	14.3	12.3	9.3	6.3	6.9	8.3	3.5	1.7	1.2	2.1	1.9	1.3
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	55.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	49.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	67.64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.56	0.6	-7.4	-2.9	0.9	5.9	5.1	0	-2.2	-0.7	-1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0.5	1.4	1.2	1.4	1.2	1.1	1.2	1.1	0.8	0.8	0.7	0.9	0.9
income-statement-row.row.operating-expenses	172.55	172.6	227.5	258.2	280.6	295	233.9	220.7	172.2	96.9	74.6	54.5	23.8	11.7	11.2	11.5	23.8	24	18.9	13.9	14.7	11.5	10.2	10.7	7.1	11.3	11.8	12.3	16.3	14.9	15.9	18.7	9.9	5.7	5.9	7.4	7.8	5.4
income-statement-row.row.cost-and-expenses	237.66	237.7	282.3	304.2	316.8	356.7	261.4	225.3	172.2	96.9	74.6	54.5	23.8	11.7	11.2	11.5	23.8	24	18.9	13.9	14.7	11.5	10.6	11.1	7.7	17.7	17.5	18.3	25.7	24.7	24.9	30.3	13.7	6.8	7.1	8.1	8.4	5.8
income-statement-row.row.interest-income	1.23	3.4	1.6	0.4	3.6	7.3	6	1	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	3	3.9	2.5	2.4	1.9	1.5	2.7	3.9	2.7	1	0.9	0.8	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	67.64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	0.06	0.1	-7.4	-2.9	0.9	5.9	5.1	0	-2.2	-0.7	-1.8	-0.8	-0.6	-0.4	2.7	0	-0.1	2.5	23.4	0	0	0.2	0.1	0.1	0	0	0.2	0.3	-1.1	-0.2	-0.3	0.9	0.8	0.4	1	0.9	1.1	0.5
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.56	0.6	-7.4	-2.9	0.9	5.9	5.1	0	-2.2	-0.7	-1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0.5	1.4	1.2	1.4	1.2	1.1	1.2	1.1	0.8	0.8	0.7	0.9	0.9
income-statement-row.row.total-operating-expenses	0.06	0.1	-7.4	-2.9	0.9	5.9	5.1	0	-2.2	-0.7	-1.8	-0.8	-0.6	-0.4	2.7	0	-0.1	2.5	23.4	0	0	0.2	0.1	0.1	0	0	0.2	0.3	-1.1	-0.2	-0.3	0.9	0.8	0.4	1	0.9	1.1	0.5
income-statement-row.row.interest-expense	3	3.9	2.5	2.4	1.9	1.5	2.7	3.9	2.7	1	0.9	0.8	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	2.9	2.9	2.9	3	2.8	2	1.5	1.5	1.1	0.7	0.6	0.3	0.2	0.2	0.2	0.4	0.4	0.3	-0.2	0.4	0.3	0.5	0.5	0.4	-0.1	0.5	1.4	1.2	1.4	1.2	1.1	1.2	1.1	0.8	0.8	0.7	0.9	0.9
income-statement-row.row.ebitda-caps	-107.72	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-110.61	-110.6	-174.7	-217.8	-228.2	-210.7	-183.9	-194.6	-170.9	-96.9	-74.6	-54.5	-23.8	-11.1	-9.9	-10.2	-23.4	-23.6	-18.9	-8.5	-9.3	-6.6	-4.8	-6.7	-4.3	2.7	2.5	-0.3	-7	-8.6	-9	-10.4	-6.4	-4	-4.7	-5.3	-5.9	-4.1
income-statement-row.row.income-before-tax	-110.56	-110.6	-182	-220.7	-227.3	-204.7	-178.8	-197.5	-173.1	-97.6	-76.4	-55.3	-24.4	-11.4	-7.2	-10.2	-23.1	-19.8	5.5	-8.5	-9.3	-6.5	-4.8	-6.6	-4.3	0	2.7	0	-8.1	-8.8	-9.3	-9.5	-5.8	-4	-3.7	-4.4	-4.8	-3.6
income-statement-row.row.income-tax-expense	-0.29	0	-47.5	-3	-2.8	0	7.8	3.9	-1.1	-0.7	-0.6	-0.3	-1.3	0.4	-2.6	-0.1	-0.3	0	0.1	-0.3	-0.1	-2.2	-1	-4.2	-12.9	0.3	0.6	0.7	2.4	0.8	0.8	-0.5	-0.2	0.3	-0.8	-0.8	-0.9	-0.3
income-statement-row.row.net-income	-110.26	-110.6	-134.5	-217.7	-224.4	-204.7	-178.8	-197.5	-173.1	-97.6	-76.4	-55.3	-23.3	-11.8	-7.3	-10	-23.1	-20.2	5.3	-8.2	-9.2	-4.4	-3.8	-2.5	8.6	2.4	1.9	-0.7	-9.4	-9.4	-9.8	-9.9	-5.6	-4.3	-3.9	-4.5	-5	-3.8